BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B.
BEXSERO is approved for use in individuals 10 through 25 years of age.
BEXSERO meningitis B vaccine that can be completed in as fast as 1 month with just 2 doses.
The meningitis vaccine most people may have received when they were younger covered meningitis ACWY, not meningitis B. That's because a meningitis B vaccine wasn't available until 2014.